Please note that the ASTRAL trial and its associated sub-studies closed to recruitment in October 2007.

  • Any patient with atherosclerotic renovascular disease (ARVD) and at least one ARVD lesion that is suitable for balloon angioplasty and/or stenting confirmed by angiogram.
  • No prior revascularisation procedure for ARVD.
  • No definite contraindication to revascularisation and unlikely that revascularisation will become indicated within the next 6 months.

 Please Note: Patients with Fibromuscular Dysplasia are not eligible.